Search results
Author(s):
Mattia Arrigo
,
Lars Christian Huber
,
Stephan Winnik
,
et al
Added:
3 years ago
In 1616, Sir William Harvey was the first person to describe the importance of right ventricular function.1 However, the right ventricle (RV) has received little attention in the past, with cardiology dealing mostly with the diseases of the left ventricle (LV) and their potential treatment. Since the early 1950s, however, the prognostic significance of RV function has been recognised in several…
View more
Author(s):
Ersilia M DeFilippis
,
Veli K Topkara
,
Ajay J Kirtane
,
et al
Added:
1 year ago
Author(s):
Vineet Agrawal
,
Kelly A Costopoulos
,
Mohammed Chowdhary
,
et al
Added:
2 years ago
Choosing between LVAD and BiVAD
Author(s):
Sajad Shehab
,
Christopher S Hayward
Added:
3 years ago
Article
Author(s):
Medhat Soliman
,
Nizar Attallah
,
Houssam Younes
,
et al
Added:
2 years ago
Carina Blomström-Lundqvist
Job title: Professor of Cardiology
Author
Author(s):
Edo Y Birati
,
Mariell Jessup
Added:
3 years ago
Heart failure (HF) is a leading cause of morbidity and mortality worldwide, affecting 1–2% of the adult population in western countries with incidence of 5–10 per 1000 persons per year.1,2 It is estimated that the prevalence of HF will continue to increase as the population ages and, according to the American Heart Association (AHA), by the year 2030 the prevalence of HF in the US alone will rise…
View more
Author(s):
Lars H Lund
Added:
1 year ago
Prof Lars Lund (Karolinska Institute, SE) outlines the findings of the ALLEVIATE-HF-1 and ALLEVIATE-HF-2 studies at 6 months. Presented at Heart Failure 22, this study aimed to evaluate a no-implant shunt in patients with chronic heart failure.
Discussion Points:
1. Aims of This Study
2. No-Implant Interatrial Shunt
3. Inclusion and Exclusion Criteria, Patient Cohort and Study Design
4. Key…
View more
Author(s):
Sriram D Rao
,
Srinath Adusumalli
,
Jeremy A Mazurek
Added:
3 years ago
Heart failure (HF) remains one of the most common medical conditions worldwide, placing a continuously growing burden on healthcare providers. Within the HF population itself, the subset of patients who develop pulmonary hypertension (PH-LHD) has been identified as having a significantly higher morbidity and mortality.1 There are limited therapeutic options for PH-LHD and it often complicates the…
View more
Author(s):
Isabella Leo
,
Eleni Nakou
,
Antonio de Marvao
,
et al
Added:
1 year ago